`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`Plaintiffs,
`
`
`
`v.
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GmbH,
`
`
`
`
`
`MODERNA, INC. and MODERNATX, INC.
`
`Defendants.
`
`
`MODERNA, INC. and MODERNATX, INC.,
`
`
`
`
`
`
`
`C.A. No. 22-252 (MSG)
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`Counterclaim-Plaintiffs,
`
`
`
`v.
`
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GmbH,
`
`
`Counterclaim-Defendants.
`
`
`
`
`
`DEFENDANTS’ OMNIBUS MOTION TO SEAL AND [PROPOSED] ORDER
`
`Pursuant to the Protective Order (D.I. 91) as modified by the Court’s November 14, 2023
`
`Order (D.I. 155), Defendants Moderna, Inc. and ModernaTX, Inc. (“Moderna”) respectfully
`
`move this Court for an order granting leave to file partially redacted versions of Plaintiffs’ Letter
`
`Brief in Support of Plaintiffs’ Motion for Leave to Amend Complaint and the exhibits thereto
`
`(collectively, “Plaintiffs’ Motion to Amend”) (D.I. 278); Plaintiffs’ Letter Brief in Support of
`
`Plaintiffs’ Motion to Compel and the exhibits thereto (collectively, “Plaintiffs’ Motion to
`
`Compel Bancel Documents”) (D.I. 285); Moderna’s Opposition to Plaintiffs’ Motion to Compel
`
`Bancel Documents and the exhibits thereto (collectively, “Moderna’s Bancel Opposition”) (D.I.
`
`294); and Moderna’s Opposition to Plaintiffs’ 30(b)(6) Motion to Compel and the exhibit thereto
`
`(collectively, “Moderna’s 30(b)(6) Opposition”) (D.I. 302).
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 322 Filed 05/17/24 Page 2 of 7 PageID #: 18741
`
`
`
`
`
`Moderna’s motion and supporting papers redact for Moderna’s confidential information
`
`in Plaintiffs’ Motion to Amend and Exhibits A–D, F, J, and M–N; Plaintiffs’ Motion to Compel
`
`Bancel Documents and Exhibits C–F and K–P; Exhibit T to Moderna’s Bancel Opposition; and
`
`Exhibit 14 to Moderna’s 30(b)(6) Opposition, which include, reference, and/or quote,
`
`Moderna’s sensitive and confidential information. The grounds for the motion are set forth in
`
`Moderna’s brief in support of this motion, as well as the Declaration of Don Parsons and the
`
`Declaration of Hamilton Bennett attached thereto. Redacted versions of these documents will
`
`be filed separately on the docket.
`
`WHEREFORE, Moderna respectfully requests that the Court grant Moderna’s motion
`
`and enter the enclosed order permitting Moderna to file a redacted versions of Plaintiffs’ Motion
`
`to Amend; Plaintiffs’ Motion to Compel Bancel Documents; Moderna’s Bancel Opposition; and
`
`Moderna’s 30(b)(6) Opposition.
`
`2
`
`
`
`Case 1:22-cv-00252-MSG Document 322 Filed 05/17/24 Page 3 of 7 PageID #: 18742
`
`
`
`
`
`
`
`OF COUNSEL:
`
`James F. Hurst
`KIRKLAND & ELLIS LLP
`300 North LaSalle
`Chicago, IL 60654
`(312) 862-2000
`
`Patricia A. Carson, Ph.D.
`Jeanna M. Wacker, P.C.
`Mark C. McLennan
`Caitlin Dean
`N. Kaye Horstman
`Shaoyao Yu
`KIRKLAND & ELLIS LLP
`601 Lexington Avenue
`New York, NY 10022
`(212) 446-4679
`
`Yan-Xin Li
`KIRKLAND & ELLIS LLP
`555 California Street, 27th Floor
`San Francisco, CA 94104
`(415) 439-1400
`
`Alina Afinogenova
`KIRKLAND & ELLIS LLP
`200 Clarendon Street
`Boston, MA 02116
`(617) 385-7500
`
`May 17, 2024
`
`
`
`
`
`
`
`MORRIS, NICHOLS, ARSHT & TUNNELL LLP
`
`/s/ Travis J. Murray
`
`
`
`
`Jack B. Blumenfeld (#1014)
`Brian P. Egan (#6227)
`Travis J. Murray (#6882)
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`(302) 658-9200
`jblumenfeld@morrisnichols.com
`began@morrisnichols.com
`tmurray@morrisnichols.com
`
`Attorneys for Defendants
`
`
`3
`
`
`
`Case 1:22-cv-00252-MSG Document 322 Filed 05/17/24 Page 4 of 7 PageID #: 18743
`
`
`
`RULE 7.1.1 CERTIFICATE
`
`I hereby certify that the subject of the foregoing motion has been discussed with counsel
`
`for the plaintiffs and that plaintiffs do not oppose this motion.
`
`/s/ Travis J. Murray
`
`Travis J. Murray (#6882)
`
`
`
`
`
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 322 Filed 05/17/24 Page 5 of 7 PageID #: 18744
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`Plaintiffs,
`
`
`
`v.
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GmbH,
`
`
`
`
`
`MODERNA, INC. and MODERNATX, INC.
`
`Defendants.
`
`
`MODERNA, INC. and MODERNATX, INC.,
`
`
`
`
`
`
`
`C.A. No. 22-252 (MSG)
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`Counterclaim-Plaintiffs,
`
`
`
`v.
`
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GmbH,
`
`
`Counterclaim-Defendants.
`
`
`
`
`
`[PROPOSED] ORDER
`
`The Court, having considered Moderna’s Omnibus Motion to Seal (the “Motion”), IT IS
`
`HEREBY ORDERED this day of
`
` , 2024 that the Motion is GRANTED.
`
`Leave is given for Moderna to file Plaintiffs’ Letter Brief in Support of Plaintiffs’ Motion
`
`for Leave to Amend Complaint and the exhibits thereto (D.I. 278); Plaintiffs’ Letter Brief in
`
`Support of Plaintiffs’ Motion to Compel and the exhibits thereto (D.I. 285); Moderna’s Opposition
`
`to Plaintiffs’ Motion to Compel Bancel Documents and the exhibits thereto (D.I. 294); and
`
`Moderna’s Opposition to Plaintiffs’ 30(b)(6) Motion to Compel and the exhibit thereto (D.I. 302)
`
`in redacted form.
`
`
`__________________________
`United States District Judge
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 322 Filed 05/17/24 Page 6 of 7 PageID #: 18745
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on May 17, 2024, I caused the foregoing to be electronically filed with
`
`the Clerk of the Court using CM/ECF, which will send notification of such filing to all registered
`
`participants.
`
`I further certify that I caused copies of the foregoing document to be served on May 17,
`
`2024, upon the following in the manner indicated:
`
`VIA ELECTRONIC MAIL
`
`VIA ELECTRONIC MAIL
`
`VIA ELECTRONIC MAIL
`
`John W. Shaw, Esquire
`Karen E. Keller, Esquire
`Nathan R. Hoeschen, Esquire
`Emily S. DiBenedetto, Esquire
`SHAW KELLER LLP
`I.M. Pei Building
`1105 North Market Street, 12th Floor
`Wilmington, DE 19801
`Attorneys for Plaintiffs Arbutus Biopharma
`Corporation and Genevant Sciences GmbH
`
`Daralyn J. Durie, Esquire
`Adam R. Brausa, Esquire
`Eric C. Wiener, Esquire
`Annie A. Lee, Esquire
`Shaelyn K. Dawson, Esquire
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, CA 94105-2482
`Attorneys for Plaintiff Arbutus Biopharma
`Corporation
`
`Kira A. Davis, Esquire
`MORRISON & FOERSTER LLP
`707 Wilshire Boulevard
`Los Angeles, CA 90017-3543
`Attorneys for Plaintiff Arbutus Biopharma
`Corporation
`
`
`
`
`
`
`Case 1:22-cv-00252-MSG Document 322 Filed 05/17/24 Page 7 of 7 PageID #: 18746
`
`VIA ELECTRONIC MAIL
`
`VIA ELECTRONIC MAIL
`
`
`
`David N. Tan, Esquire
`MORRISON & FOERSTER LLP
`2100 L Street, NW, Suite 900
`Washington, DC 20037
`Attorneys for Plaintiff Arbutus Biopharma
`Corporation
`
`David I. Berl, Esquire
`Adam D. Harber, Esquire
`Thomas S. Fletcher, Esquire
`Jessica Palmer Ryen, Esquire
`Shaun P. Mahaffy, Esquire
`Anthony H. Sheh, Esquire
`Philip N. Haunschild, Esquire
`Falicia Elenberg, Esquire
`Jihad J. Komis, Esquire
`Matthew W. Lachman, Esquire
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue S.W.
`Washington, DC 20024
`Attorneys for Plaintiff Genevant Sciences GmbH
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Travis J. Murray
`
`
`
`
`Travis J. Murray (#6882)
`
`
`
`
`
`2
`
`